Currently set to Index
Currently set to Follow
ask age2b

Long-Term Melatonin Treatment for the Sleep Problems and Aberrant Behaviors of Children With Neurodevelopmental Disorders

By AGE2B team
July 27, 2021

Main idea: Long-term melatonin treatment in combination with adequate sleep hygiene interventions may give clinical benefits to children with neurodevelopmental disorders  and potentially elevates their well-being.


Clinical evidence on the long-term efficacy and safety of melatonin treatment for sleep problems in children with neurodevelopmental disorders (NDDs) who underwent adequate sleep hygiene interventions is required.

Methods: 26-week multi center collaborative uncontrolled open-label phase III clinical trial of melatonin granules in children 6 to 15 years of age who had NDDs and sleep problems was conducted.

Results: Between June 2016 and July 2018, 99 children (80 males and 19 females, 10.4 years in mean age) were enrolled at 17 medical institutions in Japan-74, 60, 22, 9, 6, and 1 of whom had autism spectrum disorder, attention-deficit/hyperactivity disorder, intellectual disabilities, motor disorders, specific learning disorder, and communication disorders, respectively, at baseline. Fifteen children received the maximum dose of 4 mg among the prespecified dose levels. SOL recorded with the electronic sleep diary shortened significantly in the medication phase I from baseline, and the SOL-shortening effect of melatonin persisted in the medication phase II and the follow-up phase. Temper upon wakening and sleepiness after awakening improved significantly in the medication phase I from baseline and persisted in the follow-up phase. The following subscales of the ABC-J improved significantly: stereotypic behavior in the medication phase I; and irritability, hyperactivity, and inappropriate speech in the medication phase II. Treatment-emergent adverse events did not occur 16 weeks after medication onset, and NDDs did not deteriorate in the follow-up phase.

Source BMC

Leave a Reply

Ask your question

We read all your emails and your text. Your question will be responded by our specialists, or one of the doctors we're working with, or our community

Please complete the required fields.